Efficacy and safety of Limosilactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis in children: a systematic review and meta-analysis of randomized controlled trials

Ener Cagri Dinleyici, Flavia Indrio, Pedro Gutierrez-Castrellon, Dimas Rosa

Open source

DOI
10.3389/fped.2026.1941872
Published
2026-10-16
Container
Frontiers in Pediatrics
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2026.1941872,
  title = {Efficacy and safety of Limosilactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis in children: a systematic review and meta-analysis of randomized controlled trials},
  author = {Ener Cagri Dinleyici and Flavia Indrio and Pedro Gutierrez-Castrellon and Dimas Rosa},
  year = {2026},
  journal = {Frontiers in Pediatrics},
  doi = {10.3389/fped.2026.1941872},
  url = {https://doi.org/10.3389/fped.2026.1941872}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of Limosilactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis in children: a systematic review and meta-analysis of randomized controlled trials
AU  - Ener Cagri Dinleyici
AU  - Flavia Indrio
AU  - Pedro Gutierrez-Castrellon
AU  - Dimas Rosa
PY  - 2026
JO  - Frontiers in Pediatrics
DO  - 10.3389/fped.2026.1941872
UR  - https://doi.org/10.3389/fped.2026.1941872
ER  - 

APA

Dinleyici, E. C., Indrio, F., Gutierrez-Castrellon, P., & Rosa, D. (2026). Efficacy and safety of Limosilactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis in children: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2026.1941872

Source records